Preventive healthcare startup CENT has emerged from stealth with its first clinic in Bengaluru, aiming to detect serious illnesses at their earliest stages through comprehensive screening and AI-driven analysis. Founded by Practo co-founder Shashank ND alongside Arpit Garg and Anshul Khandelwal, the venture focuses on catching conditions before symptoms appear, when interventions are most effective.
AI-enabled screening across major disease areas
CENT’s clinical model is built around its CCNM protocol, targeting four high-burden domains: cardiovascular, cancer, neurological and metabolic diseases. The programme combines advanced imaging and diagnostics—including whole-body MRI, CT coronary calcium scoring, DEXA scans, ECG, and more than 120 blood and urine biomarkers—with machine-learning analysis to screen for over 300 conditions.
Participants receive a consolidated risk assessment called the Tru10 score, which presents organ-level risk profiles and flags findings requiring follow-up. The approach is designed to move detection to “Stage 0” and “Stage 1,” improving treatment outcomes and reducing downstream healthcare costs.
Early results from Bengaluru operations
In its initial rollout, CENT reports conducting approximately 1,500–2,000 scans. Of these, about 26% of individuals required clinical follow-up, while 3–4% had serious findings necessitating immediate care. The company says its detection rates outperform conventional health check-ups, highlighting the value of multi-modal screening and longitudinal risk tracking.
Funding, pricing and expansion roadmap
The startup has raised around $5 million in seed capital from OneFlow Holdings and South Park Commons. It reports month-on-month growth of about 50% and an annualised revenue run rate near $2 million, reflecting early demand for preventive health services.
CENT’s first facility in Koramangala is purpose-built for preventive screening rather than routine diagnostics. The company has partnered with Siemens Healthineers to enhance imaging quality and workflow. Its flagship Scan X package is priced at ₹27,500, with an optional genetic testing add-on available at the same price. Expansion to Mumbai, Delhi-NCR, Pune and Hyderabad is planned, as CENT seeks to scale access to proactive, data-driven health assessments across major Indian cities.
